Stellate Therapeutics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 10

Stellate Therapeutics General Information

Description

Developer of microbiome-derived molecules intended to fight age-related neurological diseases. The company focuses on performing comprehensive research on gut-brain axis pathologies and developing the drug candidate, a potential first-in-class therapy for Parkinson's disease, thereby enabling access to an effective cure.

Contact Information

Formerly Known As
Amabiotics
Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Corporate Office
  • 47 Rue de Montmorency
  • 75003 Paris
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 47 Rue de Montmorency
  • 75003 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stellate Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Stellate Therapeutics‘s full profile, request access.

Request a free trial

Stellate Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stellate Therapeutics FAQs

  • When was Stellate Therapeutics founded?

    Stellate Therapeutics was founded in 2009.

  • Where is Stellate Therapeutics headquartered?

    Stellate Therapeutics is headquartered in Paris, France.

  • What is the size of Stellate Therapeutics?

    Stellate Therapeutics has 10 total employees.

  • What industry is Stellate Therapeutics in?

    Stellate Therapeutics’s primary industry is Drug Discovery.

  • Is Stellate Therapeutics a private or public company?

    Stellate Therapeutics is a Private company.

  • What is Stellate Therapeutics’s current revenue?

    The current revenue for Stellate Therapeutics is .

  • How much funding has Stellate Therapeutics raised over time?

    Stellate Therapeutics has raised $12M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process